Precision Optics (NASDAQ:POCI) Releases Quarterly Earnings Results

Precision Optics (NASDAQ:POCI) posted its quarterly earnings data on Thursday. The company reported ($0.15) EPS for the quarter, Zacks reports. The company had revenue of $4.53 million during the quarter. Precision Optics had a negative return on equity of 35.51% and a negative net margin of 20.01%.

Precision Optics Price Performance

Precision Optics stock traded down $0.08 during mid-day trading on Friday, hitting $4.91. The stock had a trading volume of 12,960 shares, compared to its average volume of 8,397. The firm has a market capitalization of $31.18 million, a P/E ratio of -7.92 and a beta of 0.28. The company has a current ratio of 1.41, a quick ratio of 0.76 and a debt-to-equity ratio of 0.17. The firm’s 50 day moving average is $5.01 and its 200 day moving average is $5.05. Precision Optics has a one year low of $3.47 and a one year high of $6.90.

Insider Buying and Selling

In related news, Director Peter V. Anania sold 14,400 shares of the company’s stock in a transaction on Wednesday, November 20th. The shares were sold at an average price of $5.00, for a total value of $72,000.00. Following the completion of the transaction, the director now owns 196,198 shares of the company’s stock, valued at approximately $980,990. This represents a 6.84 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. 16.30% of the stock is currently owned by insiders.

About Precision Optics

Precision Optics Corporation, Inc designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians.